# Ovid Therapeutics Inc.: Form 8-K, filed Jun 11, 2026

- Company: [Ovid Therapeutics Inc.](/companies/ovid.md) (CIK 1636651)
- Form: 8-K
- Filed: 2026-06-11
- Accepted by EDGAR: Jun 11, 2026, 09:03 ET
- Period: 2026-06-11
- Accession: 0001628280-26-042396
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1636651/000162828026042396/ovid-20260611.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1636651/000162828026042396/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1636651/000162828026042396/ovid-20260611.htm

Filed Jun 11, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-042396. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.